For the study, researchers examined Medicare data from 2008 to 2010 on 1,165,165 patients aged 65 years and older. Among these, 6,838 experienced C. diff infections.
Patients diagnosed with C. diff were more likely to be older, from the Northeast and demonstrated a higher burden of comorbidities. C. diff infections were associated with a near doubling in mortality rates (23.4 percent to 42.6 percent) when compared to uninfected Medicare patients. Healthcare costs also nearly doubled for infected patients.
“Among elderly patients, [C. diff infection] is associated with an increase in adjusted mortality and healthcare costs following a CDI episode,” wrote the authors. “Nationwide, annually this equals 240,000 patients with CDI, 46,000 potential deaths, and more than $6 billion in costs.”
More articles on infection control:
3 things to know about sepsis simulation training
Antibiotics to stall New York Legionnaires’ disease probe
HHS report identifies 7 new cancer-causing substances
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
